2026 NPPES data Addiction Medicine (Psychiatry & Neurology) Physician NPI 1831380989
Verify on CMS →

LUBA CHANIN

Addiction Medicine (Psychiatry & Neurology) Physician in BROOKLYN, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 94 beneficiaries · Addiction Medicine (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

LUBA CHANIN filed 2,872 Medicare Part D claims in 2023 as a Addiction Medicine (Psychiatry & Neurology) Physician in BROOKLYN, New York, prescribing 93% generic.

3K
Part D claims, 2023
93%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LUBA CHANIN's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,872 Top 12% higher than 88% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

LUBA CHANIN practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LUBA CHANIN?

Quality data not reported

NPI registry status

Active

Issued 08/05/2007

NPI 1831380989

Primary specialty

Addiction Medicine (Psychiatry & Neurology) Physician

Niche

658 US NPIs in this specialty

Medicare Part D claims

2,872 182% vs specialty avg

2023 prescription claims

Specialty avg: 1,019

Specialty distribution in New York

How Addiction Medicine (Psychiatry & Neurology) Physician compares to other specialties among New York providers

New York providers

Addiction Medicine (Psychiatry & Neurology) Physician share within New York

1. Addiction Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Psychiatry & Neurology) Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Medicine (Psychiatry & Neurology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Medicine (Psychiatry & Neurology) Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Medicine (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LUBA CHANIN appears in the CMS NPPES registry as a Addiction Medicine (Psychiatry & Neurology) Physician provider at 132 GRAHAM AVE, BROOKLYN, NY, 11206, with a listed phone of (718) 387-4200. NPI 1831380989 was issued on 08/05/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHANIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,872 prescription claims written by this provider, covering 94 Medicare beneficiaries and totaling roughly $115K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 658 enrolled providers across 49 states and an average of 1,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

132 GRAHAM AVE
BROOKLYN, NY 11206

Provider Details

NPI 1831380989
Specialty Addiction Medicine (Psychiatry & Neurology) Physician
Gender Female
NPI Issued 08/05/2007

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to LUBA CHANIN. To verify LUBA CHANIN's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

LUBA CHANIN — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 2,872 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,872
Total Claims
$115K
Total Drug Cost
94
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,876
Total Day Supply
56,021
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$92K
Generic Drug Cost
$23K

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
1.36
Gender Split
71% female / 29% male
Age Distribution
<65: 18, 65-74: 31, 75-84: 27, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LUBA CHANIN prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Alprazolam
474
Zolpidem Tartrate
267
Donepezil Hcl
237
Sertraline Hcl
230
Lorazepam
191
Trazodone Hcl
190
Escitalopram Oxalate
161
Clonazepam
135
Quetiapine Fumarate
134
Paroxetine Hcl
129

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Psychiatry & Neurology) Physician Overview

How LUBA CHANIN fits within the Addiction Medicine (Psychiatry & Neurology) Physician landscape nationally.

658
Addiction Medicine (Psychiatry & Neurology) Physician Providers in US
49
States with Addiction Medicine (Psychiatry & Neurology) Physician
1,019
Avg Claims per Provider

LUBA CHANIN's 2,872 claims are above the specialty average of 1,019.

Nearby Addiction Medicine (Psychiatry & Neurology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as CHANIN.

Compare Addiction Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LUBA CHANIN's specialty?
LUBA CHANIN specializes in Addiction Medicine (Psychiatry & Neurology) Physician and practices in BROOKLYN, New York.
How much does LUBA CHANIN prescribe under Medicare Part D?
In 2023, LUBA CHANIN wrote 2,872 Medicare Part D claims totaling $115K in drug costs for 94 beneficiaries.
Where is LUBA CHANIN located?
LUBA CHANIN is located at 132 GRAHAM AVE, BROOKLYN, NY, 11206. Phone: (718) 387-4200.
What is LUBA CHANIN's NPI number?
LUBA CHANIN's National Provider Identifier (NPI) is 1831380989, issued on 08/05/2007.
Does LUBA CHANIN prescribe more brand-name or generic drugs?
LUBA CHANIN's prescribing is 7% brand-name and 93% generic drugs by claim count, with $92K in brand drug costs.
How many Addiction Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 658 Addiction Medicine (Psychiatry & Neurology) Physician providers across 49 states in the US. The average Addiction Medicine (Psychiatry & Neurology) Physician provider writes 1,019 Medicare Part D claims per year.
What drugs does LUBA CHANIN prescribe most often?
Based on 2023 Medicare Part D data, LUBA CHANIN's most frequently prescribed drugs include Alprazolam, Zolpidem Tartrate, Donepezil Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LUBA CHANIN accept Medicare?
LUBA CHANIN appears in CMS Medicare data with 2,872 Part D claims and 94 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LUBA CHANIN's credentials?
LUBA CHANIN's NPI is 1831380989. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology